Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA277506
Max Phase: Preclinical
Molecular Formula: C43H62N8O10
Molecular Weight: 851.01
Molecule Type: Protein
Associated Items:
ID: ALA277506
Max Phase: Preclinical
Molecular Formula: C43H62N8O10
Molecular Weight: 851.01
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)C(C)C
Standard InChI: InChI=1S/C43H62N8O10/c1-21(2)17-30(44)38(55)49-35(23(5)6)42(59)50-34(22(3)4)41(58)48-32(18-26-13-15-28(53)16-14-26)39(56)46-24(7)37(54)47-33(40(57)51-36(25(8)52)43(60)61)19-27-20-45-31-12-10-9-11-29(27)31/h9-16,20-25,30,32-36,45,52-53H,17-19,44H2,1-8H3,(H,46,56)(H,47,54)(H,48,58)(H,49,55)(H,50,59)(H,51,57)(H,60,61)/t24-,25+,30-,32-,33-,34-,35-,36-/m0/s1
Standard InChI Key: DIFAXGBTOGVZDQ-DTSDQQARSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 851.01 | Molecular Weight (Monoisotopic): 850.4589 | AlogP: 0.74 | #Rotatable Bonds: 22 |
Polar Surface Area: 294.17 | Molecular Species: ACID | HBA: 10 | HBD: 11 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.83 | CX Basic pKa: 8.11 | CX LogP: -0.56 | CX LogD: -0.62 |
Aromatic Rings: 3 | Heavy Atoms: 61 | QED Weighted: 0.07 | Np Likeness Score: 0.18 |
1. Jung KY, Moon HD, Lee GE, Lim HH, Park CS, Kim YC.. (2007) Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist., 50 (18): [PMID:17676725] [10.1021/jm070114m] |
Source(1):